We are now pleased to be able to offer a new procedure available to patients with superficial venous insufficiency, the condition leading to the development of symptomatic varicose veins.
Unlike other thermal-based endovenous techniques such as endovenous laser ablation (EVLA) or radiofrequency ablation, Clarivein® does not employ heat to promote closure of treated veins. Rather, Clarivein®, an FDA-approved procedure, employs a process of mechanical occlusion with a chemical assist, or MOCA.
As the acronym MOCA suggests, the technique involves the use of a mechanical device along with sclerotherapy injection of the vein to be treated. Clarivein® infusion catheter system is a specialized catheter with a unique rotating dispersion tip that allows for better, more effective, 360-degree coverage of a sclerosant chemical to treat the incompetent vein. Thermal closure techniques require the use of tumescent local anesthesia: dilute local anesthetic placed around the segment of the vein being treated. Ironically, this is the only part of the procedure that causes discomfort. In contrast, Clarivein® does not require the use of a local anesthetic around the vein. While EVLA is well-tolerated, studies have shown up to 74% less pain experienced by patients who are treated with Clarivein®.
Other benefits to using this new technique aside from minimal discomfort during the procedure include:
• Decreased risk of bruising
• Decreased overall procedure time
• Potentially decreased recovery time
During your initial consultation, we will be able to determine if you are a potential candidate for this exciting new procedure.
To learn more about varicose and spider vein treatment, please call 847-459-6400 or contact us to make an appointment.